Progress in HPV vaccination in low- and lower-middle-income countries.
about
The investment case for cervical cancer elimination.Prevalence, incidence and correlates of low risk HPV infection and anogenital warts in a cohort of women living with HIV in Burkina Faso and South Africa.Cervical cancer prevention for all women: Why now?Prevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination
P2860
Progress in HPV vaccination in low- and lower-middle-income countries.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Progress in HPV vaccination in low- and lower-middle-income countries.
@en
Progress in HPV vaccination in low- and lower-middle-income countries.
@nl
type
label
Progress in HPV vaccination in low- and lower-middle-income countries.
@en
Progress in HPV vaccination in low- and lower-middle-income countries.
@nl
prefLabel
Progress in HPV vaccination in low- and lower-middle-income countries.
@en
Progress in HPV vaccination in low- and lower-middle-income countries.
@nl
P2093
P2860
P356
P1476
Progress in HPV vaccination in low- and lower-middle-income countries.
@en
P2093
Cathy Ndiaye
D Scott LaMontagne
Julia M L Brotherton
Katherine E Gallagher
Ousseynou Badiane
Paul J N Bloem
P2860
P356
10.1002/IJGO.12186
P478
138 Suppl 1
P577
2017-07-01T00:00:00Z